相关实验视频
Updated: May 13, 2026

08:48
Targeted in Situ Mutagenesis of Histone Genes in Budding Yeast
Published on: January 26, 2017
15.4K
在发芽的酵母中,铜诱导的in vivo基因放大
Junyi Wang1, Jingya Song1, Cong Fan1
1State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Fujian 361102, China.
Biodesign research
|March 29, 2024
概括
研究人员在酵母中开发了铜诱导的基因放大,用于高水平的蛋白质生产. 这种方法增强了多拷贝基因表达和代谢工程应用,使用一种新型的对铜敏感菌株.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 酵母遗传学 酵母遗传学
背景情况:
- 多复制基因集成对于高水平的重组蛋白质生产和生物技术中的多基因通路组装至关重要.
- 像CUP1这样的抗铜基因通常是酵母系统中操纵的目标.
- 开发高效的基因放大策略对于代谢工程和蛋白质过度生产至关重要.
研究的目的:
- 开发一种用于芽酵母中铜诱导的体内基因放大新的方法.
- 为了创建一个对铜敏感的酵母菌株,以有效选择压力.
- 为了实现高水平的多拷贝基因表达和蛋白质过度生产.
主要方法:
- 通过删除CUP1基因,构建了一个对铜敏感的酵母菌株.
- 整合了一个记者基因与反转移子 (Ty) δ位点的不稳定CUP1融合.
- 应用了100μM Cu2+用于选择和诱导基因放大.
- 研究了在CUP1位点的染色体重排和并联重复,以增强表达.
主要成果:
- 成功创建了一个对铜敏感的酵母菌株.
- 证明铜诱导的体内基因放大用于多拷贝基因表达.
- 在更高的铜度下,展示了染色体重组的调节,以增加蛋白质产量.
- 在高铜下,在CUP1位点实现了表达卡塞特的协同重复.
结论:
- 铜诱导的体内基因放大是一种强大的方法,用于在芽酵母中过度生产蛋白质.
- 这种技术为代谢工程应用提供了有价值的工具.
- 开发的系统为增强基因表达水平提供了一个灵活的平台.
更多相关视频
相关概念视频
Transgenic Organisms
Overview
Bacterial Transformation
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Gene Regulation During Sporulation
Sporulation is a complex developmental process that allows certain Gram-positive bacteria, such as Bacillus subtilis and Clostridium species, to survive extreme environmental conditions. This process is tightly regulated by a series of signaling cascades and transcriptional controls, ensuring the formation of a highly resistant endospore.Sporulation is triggered by unfavorable conditions, such as nutrient depletion, and is governed by a phosphorelay system. One of the sensor kinases, such as...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

